US stocks rise sharply as election results keep trickling in
Shares of pharmaceuticals maker Biogen (BIIB) jumped more than 27% after the chances of approval for its Alzheimer's drug aducanumab shot higher based on evidence of effectiveness…
Shares of pharmaceuticals maker Biogen (BIIB) jumped more than 27% after the chances of approval for its Alzheimer's drug aducanumab shot higher based on evidence of effectiveness…